Furthermore, Ki-67 and DAPI based-cell cycle FACS analysis confirmed that CP CML CD34+ cells transit G1-phase slowly compared with their normal progenitor counterparts (Supplementary Fig. 3g). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.